FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

7777611000001104: Magnesium aspartate 60.8mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23467501000001110 Magnesium aspartate 60.8mg tablets 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
91139401000001113 Magnesium aspartate (magnesium 2.5mmol) tablets 50 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium aspartate 60.8mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has VMP Magnesium aspartate (magnesium 2.5mmol) tablets true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has VMP Magnesium aspartate (magnesium 2.5mmol) tablets false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Is pack of Product containing precisely magnesium aspartate 2.5 millimole/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has active ingredient Nutritional supplement false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has active ingredient Magnesium aspartate false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has VMP Product containing precisely magnesium aspartate 2.5 millimole/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has specific active ingredient Magnesium aspartate hydrochloride true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magnesium aspartate 60.8mg tablets 50 tablet Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesiocard tablets (Verla Pharm) 50 tablet Is a True Magnesium aspartate 60.8mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start